Skip to content
Sign in

ATRC · NASDAQ

AtriCure (ATRC) Stock Price & Fundamentals

$680.55−0.15%−$1.05End-of-day price as of Oct 9, 2026

AtriCure (ATRC) closed at $680.55 on Oct 9, 2026, down 0.15% from the previous close of $681.60.

Share price, past year

1Y +29.89%

52-week range $522.29 – $701.01. Daily closing prices.
Monthly closing prices
Last closing price of each month
DateClose
Oct 9, 2026$680.55
Sep 30, 2026$680.52
Aug 31, 2026$662.56
Jul 31, 2026$648.04
Jun 30, 2026$646.57
May 29, 2026$634.85
Apr 30, 2026$587.93
Mar 31, 2026$619.32
Feb 27, 2026$644.85
Jan 30, 2026$622.48
Dec 31, 2025$585.76
Nov 28, 2025$580.23
Oct 31, 2025$557.58

Key statistics

Market cap
$34.61B
P/E (TTM)
3,240.7
EPS (TTM)
$0.21
Revenue (TTM)
$569.62M
Net income (TTM)
$10.55M
Shares outstanding
50.9M
Dividend yield
—
52-week range
$522.29 – $701.01

AtriCure's market cap is $34.61B, based on a share price of $680.55 and 50.9M shares outstanding as of Jun 30, 2026.

Financials

AtriCure reported revenue of $534.53M for fiscal 2025, up 14.88% from fiscal 2024.

AtriCure reported a net loss of $11.45M in fiscal 2025.

Fiscal 2025 revenue was the highest in the 10 years shown.

Annual revenue

FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Annual revenue by fiscal year; the table below lists the values.
AtriCure annual financials by fiscal year, from SEC filings
Fiscal yearRevenueGrowthNet incomeNet marginEPS (diluted)Free cash flow
FY2025ended Dec 31, 2025$534.53M+14.9%−$11.45M−2.1%−$0.24$48.28M
FY2024ended Dec 31, 2024$465.31M+16.6%−$44.70M−9.6%−$0.95$745.00K
FY2023ended Dec 31, 2023$399.25M+20.8%−$30.44M−7.6%−$0.66−$7.51M
FY2022ended Dec 31, 2022$330.38M+20.4%−$46.47M−14.1%−$1.02−$39.02M
FY2021ended Dec 31, 2021$274.33M+32.8%$50.20M18.3%$1.09−$23.53M
FY2020ended Dec 31, 2020$206.53M−10.5%−$48.16M−23.3%−$1.14−$25.13M
FY2019ended Dec 31, 2019$230.81M+14.5%−$35.19M−15.3%−$0.94−$27.99M
FY2018ended Dec 31, 2018$201.63M+15.4%−$21.14M−10.5%−$0.62−$10.38M
FY2017ended Dec 31, 2017$174.72M+12.6%−$26.89M−15.4%−$0.83−$15.33M
FY2016ended Dec 31, 2016$155.11M—−$33.34M−21.5%−$1.05−$22.81M
AtriCure quarterly results
QuarterRevenueNet incomeEPS (diluted)
Q2 FY2026ended Jun 30, 2026$153.60M$8.96M$0.18
Q1 FY2026ended Mar 31, 2026$141.25M$108.00K$0.00
Q4 FY2025ended Dec 31, 2025$140.50M$1.76M$0.04
Q3 FY2025ended Sep 30, 2025$134.27M−$267.00K−$0.01
Q2 FY2025ended Jun 30, 2025$136.14M−$6.19M−$0.13
Q1 FY2025ended Mar 31, 2025$123.62M−$6.75M−$0.14
Q4 FY2024ended Dec 31, 2024$124.28M−$15.57M−$0.33
Q3 FY2024ended Sep 30, 2024$115.91M−$7.85M−$0.17

Company profile

Name
AtriCure, Inc.
Ticker
ATRC
Exchange
NASDAQ
Industry (SEC SIC)
Surgical & Medical Instruments & Apparatus
Headquarters
7555 Innovation Way, Mason, OH 45040
Incorporated in
DE
Fiscal year ends
December
SEC CIK
0001323885

Recent SEC filings

Frequently asked questions

What is AtriCure's stock price?

AtriCure (ATRC) closed at $680.55 on Oct 9, 2026, down 0.15% from the previous close of $681.60.

What is AtriCure's market cap?

AtriCure's market cap is $34.61B, based on a share price of $680.55 and 50.9M shares outstanding as of Jun 30, 2026.

How much revenue does AtriCure make?

AtriCure reported revenue of $534.53M for fiscal 2025, up 14.88% from fiscal 2024.

What is ATRC's P/E ratio?

AtriCure's price-to-earnings ratio is 3,240.7, based on trailing twelve-month diluted EPS of $0.21.

Does AtriCure pay a dividend?

AtriCure's recent filings report no dividends declared over the last four quarters.

Sources and methodology

Fundamentals come from AtriCure, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures